Icon of the Instituts for Quality and Efficiency in Health Care

Report

Biomarkers in primary breast cancer

Status
Status: Commission completed
Project no.
D23-01
Last updated

Report documents

  1. Extract of the final report

    Biomarkers in primary breast cancer

    published on
    Document type
    PDF document, 816 kB, EN, not accessible
    DOI-Link
    https://doi.org/10.60584/D23-01B_en
    Download file : Extract of the final report (PDF document, 816 kB, EN, not accessible)

  2. Final report

    Biomarkers in primary breast cancer

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/D23-01B
    Download file : Final report (PDF document, 2 MB, DE, not accessible)

  3. Documentation and evaluation of the hearing on the preliminary report

    Biomarkers in primary breast cancer

    published on
    Document type
    PDF document, 3 MB, DE, not accessible
    Download file : Documentation and evaluation of the hearing on the preliminary report (PDF document, 3 MB, DE, not accessible)

  4. Preliminary report

    Biomarkers in primary breast cancer

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    Download file : Preliminary report (PDF document, 2 MB, DE, not accessible)

  5. Report plan

    Biomarkers in primary breast cancer

    published on
    Document type
    PDF document, 520 kB, DE, not accessible
    Download file : Report plan (PDF document, 520 kB, DE, not accessible)

Press releases

Breast cancer: Treatment decisions on the basis of a biomarker-based test can also be harmful

Premenopausal patients may not receive the best care if they choose to forego chemotherapy that could potentially benefit them. English translation of the final report is now available.
Press release

Project details

Project no.
D23-01
Commission
Commission awarded on 12.05.2023 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Non-Drug Interventions
Topic
Cancer, Diagnostics
Note

Both commissions are processed in a joint report.

  • D23-01A: Biomarker-based tests for deciding for or against adjuvant systemic chemotherapy in primary breast cancer with involvement of 1-3 lymph nodes- Awarded by the Federal Joint Committee (G-BA) on 12 May 2023.
  • D23-01B - Biomarker-based tests for deciding for or against adjuvant systemic chemotherapy in premenopausal women with primary breast cancer without lymph node involvement - Awarded by the Federal Joint Committee (G-BA) on 21 September 2023.
DOI

Extract of final report: https://doi.org/10.60584/D23-01B_en

Final report: https://doi.org/10.60584/D23-01B

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page